Singapore markets closed

McKesson Corporation (MCK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
246.62-5.22 (-2.07%)
At close: 04:05PM EST
246.62 0.00 (0.00%)
After hours: 04:42PM EST
Full screen
Trade prices are not sourced from all markets
Previous close251.84
Bid247.38 x 1000
Ask246.00 x 900
Day's range245.74 - 252.44
52-week range169.34 - 256.85
Avg. volume975,266
Market cap37.654B
Beta (5Y monthly)0.78
PE ratio (TTM)N/A
EPS (TTM)-30.59
Earnings date02 Feb 2022
Forward dividend & yield1.88 (0.76%)
Ex-dividend date30 Nov 2021
1y target est286.31
  • Zacks

    Here is Why Growth Investors Should Buy McKesson (MCK) Now

    McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

  • Zacks

    Should Value Investors Buy These Medical Stocks?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Business Wire

    McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors

    IRVING, Texas, January 18, 2022--McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors elected James H. Hinton and Kathleen Wilson-Thompson as directors on Jan. 13, 2022. McKesson expects that the board will appoint Hinton to the Compliance Committee and Governance Committee and Wilson-Thompson to the Compensation Committee and Governance Committee. With the election of Hinton and Wilson-Thompson, McKesson’s board of directors increases from 9 to 11 members.